Bruker Corp. Stock
Bruker Corp. Stock
There is an upward development for Bruker Corp. compared to yesterday, with an increase of €1.02 (1.360%).
With 7 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 85 € shows a slightly positive potential of 12.37% compared to the current price of 75.64 € for Bruker Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bruker Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bruker Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 1.360% | 3.645% | -12.047% | - | 13.744% | - | - |
| Integer Hldg | 1.740% | 7.339% | 14.706% | 61.379% | 31.461% | 50.000% | 93.612% |
| Healthequity Inc. | - | -2.649% | 0.685% | 51.860% | 23.529% | 17.262% | - |
| Omnicell Inc. | -2.340% | -3.846% | -2.344% | -53.271% | -28.571% | -78.448% | -65.796% |
Comments
Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $66.00 to $74.00. They now have a "sell" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at UBS Group AG from $94.00 to $102.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at UBS Group AG from $86.00 to $94.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat